Pharmas active in developing antihypertensive combination drugs

Published: 2018-05-04 16:30:00
Updated: 2018-05-04 17:04:02

Ever since the incrementally modified drug system was adopted in 2009, total 16 products were approved as a combination therapy for hypertension.

Moreover, antihypertensives are reportedly moving towards a trend with the 3-way combination, ARB, CCB and diuretic.

The Ministry of Food and Drug Sa...


- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.

Original Korean

Most Read News

Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email:

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.